Age and Ageing Advance Access published online on August 12, 2006
Age and Ageing, doi:10.1093/ageing/afl075
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Pharmacy Practice and Medicines Management Group, School of Healthcare, Baines Wing, University of Leeds, PO Box 214, Leeds LS2 9UT, UK
* To whom correspondence should be addressed. Objective: to measure the impact of pharmacist-conducted clinical medication review with elderly care home residents. Design: randomised controlled trial of clinical medication review by a pharmacist against usual care. Setting: sixty-five care homes for the elderly in Leeds, UK. Participants: a total of 661 residents aged 65+ years on one or more medicines. Intervention: clinical medication review by a pharmacist with patient and clinical records. Recommendations to general practitioner for approval and implementation. Control patients received usual general practitioner care. Main outcome measures: primary: number of changes in medication per participant. Secondary: number and cost of repeat medicines per participant; medication review rate; mortality, falls, hospital admissions, general practitioner consultations, Barthel index, Standardised Mini-Mental State Examination (SMMSE). Results: the pharmacist reviewed 315/331 (95.2%) patients in 6 months. A total of 62/330 (18.8%) control patients were reviewed by their general practitioner. The mean number of drug changes per patient were 3.1 for intervention and 2.4 for control group (P < 0.0001). There were respectively 0.8 and 1.3 falls per patient (P < 0.0001). There was no significant difference for GP consultations per patient (means 2.9 and 2.8 in 6 months, P = 0.5), hospitalisations (means 0.2 and 0.3, P = 0.11), deaths (51/331 and 48/330, P = 0.81), Barthel score (9.8 and 9.3, P = 0.06), SMMSE score (13.9 and 13.8, P = 0.62), number and cost of drugs per patient (6.7 and 6.9, P = 0.5) (£42.24 and £42.94 per 28 days). A total of 75.6% (565/747) of pharmacist recommendations were accepted by the general practitioner; and 76.6% (433/565) of accepted recommendations were implemented. Conclusions: general practitioners do not review most care home patients medication. A clinical pharmacist can review them and make recommendations that are usually accepted. This leads to substantial change in patients medication regimens without change in drug costs. There is a reduction in the number of falls. There is no significant change in consultations, hospitalisation, mortality, SMMSE or Barthel scores.
Received November 16, 2005
Accepted May 5, 2006
Article
Clinical medication review by a pharmacist of elderly people living in care homes--randomised controlled trial
Arnold Geoffrey Zermansky 1 *, David Phillip Alldred 1, Duncan Robert Petty 1, David K. Raynor 1, Nick Freemantle 2, Joanne Eastaugh 2, and Peter Bowie 3
2 Department of Primary Care and General Practice, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
3 Older People’s Mental Health Department, Longley Centre, Norwood Grange Drive, Sheffield S5 7JT, UK
Arnold Geoffrey Zermansky, E-mail: a.g.zermansky{at}leeds.ac.uk/zermansky@btinternet.com
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N D Barber, D P Alldred, D K Raynor, R Dickinson, S Garfield, B Jesson, R Lim, I Savage, C Standage, P Buckle, et al. Care homes' use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older people Qual. Saf. Health Care, October 1, 2009; 18(5): 341 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C.T. Close Falls in Older People: Risk Factors, Assessment and Intervention IBMS BoneKEy, October 1, 2009; 6(10): 368 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ryan, D. O'Mahony, and S. Byrne Application of STOPP and START Criteria: Interrater Reliability Among Pharmacists Ann. Pharmacother., July 1, 2009; 43(7): 1239 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L Castelino, B. V Bajorek, and T. F Chen Targeting Suboptimal Prescribing in the Elderly: A Review of the Impact of Pharmacy Services Ann. Pharmacother., June 1, 2009; 43(6): 1096 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ostini, D. Hegney, C. Jackson, M. Williamson, J. M Mackson, K. Gurman, W. Hall, and S. E Tett Systematic Review of Interventions to Improve Prescribing Ann. Pharmacother., March 1, 2009; 43(3): 502 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Alldred, D. R. Petty, P. Bowie, A. G. Zermansky, and D. K. Raynor Antipsychotic prescribing patterns in care homes and relationship with dementia Psychiatr. Bull., September 1, 2007; 31(9): 329 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G Zermansky, D. P Alldred, D. R Petty, and D. K Raynor Striving to recruit: the difficulties of conducting clinical research on elderly care home residents J R Soc Med, June 1, 2007; 100(6): 258 - 261. [Full Text] [PDF] |
||||
![]() |
A. G Zermansky Clinical medication review is effective in care homes BMJ, January 27, 2007; 334(7586): 169 - 170. [Full Text] [PDF] |
||||
![]() |
Minerva BMJ, November 4, 2006; 333(7575): 978 - 978. [Full Text] [PDF] |
||||





